Interleukin‐4 Aggravates LPS‐Induced Striatal Neurodegeneration In Vivo via Oxidative Stress and Polarization of Microglia/Macrophages

Abstract

The present study investigated the effects of interleukin (IL)‐4 on striatal neurons in lipo-polysaccharide (LPS)‐injected rat striatum in vivo. Either LPS or PBS as a control was unilaterally injected into the striatum, and brain tissues were processed for immunohistochemical and Nissl staining or for hydroethidine histochemistry at the indicated time points after LPS injection. Analysis by NeuN and Nissl immunohistochemical staining showed a significant loss of striatal neurons at 1, 3, and 7 days post LPS. In parallel, IL‐4 immunoreactivity was upregulated as early as 1 day, reached a peak at 3 days, and was sustained up to 7 days post LPS. Increased levels of IL‐4 immu-noreactivity were exclusively detected in microglia/macrophages, but not in neurons nor astrocytes. The neutralizing antibody (NA) for IL‐4 significantly protects striatal neurons against LPS‐induced neurotoxicity in vivo. Accompanying neuroprotection, IL‐4NA inhibited activation of micro-glia/macrophages, production of reactive oxygen species (ROS), ROS‐derived oxidative damage and nitrosative stress, and produced polarization of microglia/macrophages shifted from M1 to M2. These results suggest that endogenous IL‐4 expressed in LPS‐activated microglia/macrophages contributes to striatal neurodegeneration in which oxidative/nitrosative stress and M1/M2 polarization are implicated.